Gene set enrichment analysis (GSEA) is a statistical method to determine if predefined sets of genes are differentially expressed in different phenotypes. Predefined gene sets may be genes in a known metabolic pathway, located in the same cytogenetic band, sharing the same Gene Ontology category, or any user-defined set. In microarray experiments where no single gene shows statistically significant differential expression between phenotypes, GSEA has identified significant differentially expressed sets of genes, even where the average difference in expression between two phenotypes is only 20% for genes in the gene set. The gene set identified in the first GSEA analysis (oxidative phosphorylation genes differentially expressed in diabetic versus non-diabetic patients) was subsequently confirmed by independent laboratory studies published in the New England Journal of Medicine. Since the first paper on GSEA was published, many extensions and alternative methods have been described in the literature. In this paper, we describe the original GSEA algorithm, subsequent extensions and alternatives, results of some of the applications, some limitations of the methods and caveats for users, and possible future research directions. GSEA and related methods are complementary to conventional single-gene methods. Single gene methods work best when individual genes have large effects and there is small variance within the phenotype. GSEA is likely to be more powerful than conventional single-gene methods for studying the large number of common diseases in which many genes each make subtle contributions. It is a tool that deserves to be in the toolbox of bioinformatics practitioners.
INTRODUCTION
Gene expression microarray experiments are major sources of new knowledge of genes, pathways, and disease. Pham [1] and Asyali [2] provide two recent reviews of the most widely-used bioinformatics methods to analyze gene expression data. The conventional statistical analysis method for gene expression microarray experiments is to examine one gene at a time, determine a p-value that the gene is differentially expressed in different phenotypes, and then to apply a correction (penalty) to the p-value for having tested multiple genes (described further below). Several authors have described the limitations of these single gene methods [3, 4] :
Single gene methods work best when individual genes have large effects and there is a very consistent effect for subjects with each single phenotype. When microarray experiments are replicated, we observe high variance in replicates of the same gene in the same condition (low reproducibility). As a consequence of the low reproducibility, 2-fold or greater differences in expression are typically required to achieve statistical significance. But many, perhaps most, biological processes involve less than 2-fold changes. In common diseases, a large number of genes each make subtle contributions, and these genes are difficult to detect in single gene analyses. After correction for multiple comparisons, few or no single genes may be significant, and most genes with small effects will be non-significant. (ii) When the gene expression experiment is repeated using new samples (such as a second group of patients), the overlap in the list of statistically significant genes from the two samples is often distressingly small. When a biological pathway is up-regulated or down-regulated, individual genes in the pathway may not show consistent, statistically significant effects in different samples. More subtle, coordinated changes in members of a set may be more easily detected than the change in a single member.
Gene set enrichment analysis (GSEA) was designed to address these limitations of single gene analyses [4] . It is a statistical method to determine if predefined sets of genes are differentially expressed in different phenotypes. Predefined gene sets may be from any source, such as genes in a known metabolic pathway, a Gene Ontology category, a set of coexpressed genes observed in a previous experiment, or any user-defined set.
We note that GSEA was not the first use of pre-defined sets of genes to guide statistical analyses of gene expression data, as the GSEA authors point out in their papers. Earlier algorithms based on similar concepts have been described [5, 6] . We focus on GSEA because the predictions of the method have been validated in independent laboratory experiments [7, 8] , it has provided a large impetus to increased use of gene-set methods, and it is available in an easy-to-use software package, described by an independent user as "a smooth, friendly and robust environment" [9] .
Computational algorithms for using pre-defined biological relationships (a knowledge base) to guide automated statistical analyses of biomedical data can be traced back at least to the 1980's as illustrated by [10] and reviewed in [11] .
In this paper, we describe the original GSEA algorithm, subsequent extensions and alternatives, results of some of the applications, the limitations of the methods, and possible future research directions. GSEA software is available at the website http://www.broad.mit.edu/gsea/.
MOOTHA: ORIGINAL GSEA ALGORITHM
Mootha and colleagues implemented and described the first version of the GSEA algorithm [12] . This version is the simplest to understand, and provides a good basis for understanding the subsequent extensions and alternatives. We will first give an overview of the method for the simple case where we wish to know if the genes in a pre-defined gene set are differently expressed in two different phenotypes (a twocategory outcome). We'll then look at the mathematical definition and generalize the method to continuous outcomes.
Suppose that we want to determine if a particular set of genes, S, is differentially expressed in two different phenotypes (such as diabetic versus non-diabetic samples). We first calculate an association score for each gene that measures the difference of that gene's expression in the two phenotypes. In the GSEA papers, the authors call the association score the correlation, but we'll use the more general term "association", because correlation has a more restricted statistical definition. We'll go into these association scores in more detail later, but for now we'll state that there are many choices for the measure of expression difference between two groups, including the t-test, Wilcoxon rank sum test, signal-to-noise (SNR), and others.
The t-test, SNR, and other methods for calculating the association scores use a procedure similar to the following.
• If the difference between the two means (or medians) is large, and the measure of variability is small, then the association statistics (t-statistic or SNR) is large, and gives evidence that the gene is differentially expressed between the two phenotypes. After we calculate the association score for each of the N genes in the entire data set D, we sort the genes by their association score to produce the list L. L is the list containing the N genes ranked (sorted) by their association (correlation) with the outcome of interest (phenotype).
If the gene set S is related to the phenotype, then we would expect to see that the genes in S will tend to have higher association scores than do genes in gene sets not related to the phenotype. The proportion of genes in S that rank near the top of the list L should be greater than the proportion of other genes. If we look at all the genes in the ranked gene list L up to position i, we can compare the fraction of the genes in S that are present before position i to the fraction of all the N genes (except those in S) that are present before position i. If more genes from S occur higher in the list, then that is evidence that gene set S is enriched (present more often than expected) near the top of the list. GSEA calculates the difference between (i) the fraction of the genes in S that are present before position i and (ii) the fraction of all the N genes (except those in S) that are present before position i across all possible positions i in the list L. In the Mootha version of GSEA, the Enrichment Score (ES) is the maximum difference in these fractions. In the Subramanian version, which we'll look at shortly, the ES is a slightly more complicated function of the difference in these fractions. If there is no enrichment of gene set S, then the enrichment score ES should be near zero, that is, there should be little difference in the proportion of genes in S that rank near the top of the list L and the proportion of other genes near the top of L. This maximum difference is the KolmogorovSmirnov statistic.
How much does the ES have to deviate from zero to be significant? Even if there is no enrichment of gene set S, we would expect some random fluctuation of the enrichment score ES around zero, sometimes being more and sometimes being less. To determine if the ES is significant, GSEA applies a widely used method, a permutation test. Specifically, GSEA randomly permutes the phenotype labels of the k samples, so that, in any given permutation, what previously was labeled phenotype 1 might be randomly labeled phenotype 1 or phenotype 2. We do hundreds or thousands of such permutations. For each permutation we re-calculate the enrichment score ES for the gene set S. After doing, say, 1000 permutations, we have a distribution of enrichment scores that are produced when the phenotype labels of the k samples are randomly shuffled. If the enrichment score ES for the real data is larger than the enrichment scores for more than 95 percent of the randomly-permutated data sets, then we conclude that the probability is less than p = 0.05 that the observed ES for the real data set could have occurred by change. Similarly, If the enrichment score ES for the real data is larger than the enrichment scores for more than 99 percent of the randomly-permutated data sets, then we conclude that the probability is less than p = 0.01 that the observed ES for the real data set could have occurred by change.
If we look at only one gene set S in this way, the permutation p-value is a reasonable estimate. However, suppose we look at many gene sets, perhaps 100 or 1000 gene sets. In that case, it is likely that, at a p-value of 0.05, we would see about one "significant" result out of every 20 gene sets, just due to random sampling. This problem arises because we are testing multiple hypotheses (many gene sets), and is also called the multiple comparison problem. Many methods are available to correct the p-value for testing multiple hypotheses, and we won't go into them in this article. GSEA has used two methods, based on family-wise error rate and false discovery rate, which are described in the GSEA papers and elsewhere.
Let's look at the mathematical formulation of the algorithm. We follow the notation used in the Subramanian GSEA for ease of comparison and understanding.
N is the total number of genes being examined.
k is the number of samples.
S is the gene set of interest.
L is the list containing the N genes ranked (sorted) by their association (correlation) with the outcome of interest (phenotype).
Create the list L = {g 1 , g 2 , …, g N } containing the N genes sorted by their association (correlation) scores. For each gene set, calculate P hit and P miss , the difference between (i) the fraction of the genes in S that are present before position i and (ii) the fraction of all the N genes (except those in S) that are present before position i across all possible positions i in the list L.
where N R is the number of genes from the gene set S that are present before position i.
where N-N R is the number of genes in N, but not in the gene set S, that are present before position i.
The enrichment score ES is the maximum of P hit -P miss over all positions i in the list L. This maximum difference is the Kolmogorov-Smirnov statistic, but in GSEA it is simply called the ES. Determine the statistical significance (p-value) of the Enrichment Score for each gene set using a permutation test. Specifically, the phenotype labels (Phenotype 1 vs Phenotype 2) are randomly permuted 1000 times, the Enrichment Score for the gene set is re-calculated for each permutation, and the p-value is estimated as the proportion of the 1000 random permutations that have an ES less than the ES for the actual experimental data. This first version of GSEA estimates the overall (family-wise) error rate for multiple comparisons.
SUBRAMANIAN: ORIGINAL WORK ON GSEA EXTENSIONS
Subramanian, who co-authored the original GSEA paper, and colleagues implemented several improvements and extensions to the GSEA algorithm [4] . In the Mootha version of GSEA, a gene set could have a high enrichment score because genes in the set were found more frequently than expected near the top of L, the list of genes ranked by their association with the phenotype, but could also get a high enrichment score if they were found more frequently than expected near the middle of L. Thus, the original ES would find a gene set whose genes differed greatly from a uniform distribution, whether at the top or the middle of the list L. This seemed an undesirable characteristic, on the assumption that the gene sets of real interest would have the biggest differences between the phenotypes. So Subramanian and colleagues modified the definition of P hit -P miss by introducing a weighting factor p that reduces the ES for gene sets enriched near the middle of L. As shown in the equations below, when the weighting factor p is 1, it weights the genes in S according to r j which is the strength of each gene's association with the difference in the phenotypes. When the weighting factor p is 0, the r j reduces to 1, which gives the same results as in the Mootha GSEA.
where
The Subramanian version of GSEA estimates the false discovery rate (FDR) for multiple comparisons, rather than the overall (family-wise) error rate for multiple comparisons. GSEA has several additional features that we will not describe here, including a database of pre-defined genes sets (MSigDB), the ability to identify the members of a gene set that contribute to the ES (the "Leading-Edge Subset"), and variations on the basic method. These are described in the GSEA papers and on the website.
OTHER DEVELOPMENTS ON GSEA EXTEN-SIONS
Several researchers have published improvements, extensions and alternatives to the GSEA algorithm, and we describe several of these here. In this section, we will refer to the Mootha & Subramanian implementation as the standard GSEA [12] .
Absolute Enrichment (AE): Saxena et al. In standard GSEA, individual genes are sorted by the difference in the gene's expression in the two phenotypes, or more precisely by a function of that difference (SNR or Z-score). Those genes with the largest positive differences (phenotype 1 > phenotype 2) are at the top of the list, while genes with largest negative differences (phenotype 1 < phenotype 2) are at the bottom of the list. Saxena and colleagues [13] observed that, in plausible biological settings, for example homeostatic systems, a single gene set may have some genes significantly up-regulated and some genes significantly downregulated in response to a given perturbation. Standard GSEA may have difficulty detecting such a gene set. They proposed that genes be ordered by the absolute value of the difference in each gene's expression in the two phenotypes, so that genes with either a large positive differences (phenotype 1 > phenotype 2) or a large negative differences (phenotype 1 < phenotype 2) are at the top of the list. They studied several data sets in from the GEO database at NCBI [14] and found that using absolute value for expression differences can identify apparently meaningful gene sets that were not detected by standard GSEA.
Parametric Analysis of Gene Set Enrichment (PAGE):
Kim and Volsky. In standard GSEA, the statistical signifi-cance (p-value) of the Enrichment Score for a gene set is determined using a permutation test. Specifically, the phenotype labels (Phenotype 1 vs Phenotype 2) are randomly permuted 1000 times, the Enrichment Score for the gene set is re-calculated for each permutation, and the p-value is estimated as the proportion of the 1000 random permutations that have an ES less than the ES for the actual experimental data. This procedure is relatively computationally intensive, taking perhaps 5 to 20 minutes for a typical expression data set on a modern laptop computer. Kim and Volsky [15] observed that, for a gene set that includes a sufficiently large number of genes, the permutation p-value may be approximated by a computationally more efficient procedure using the expected normal distribution of the average score of the genes in the gene set, based on the Central Limit Theorem. Based on simulation studies, they suggest that the number of genes in the gene set be 10 or more. They report that the PAGE method was able to detect genes sets not detected by standard GSEA, and that the p-values for gene sets detected by PAGE were smaller than the corresponding GSEA pvalues. Is the normal approximation method preferable to the standard GSEA permutation method? Kim and Volsky indicate that the expression values (fold change) of the genes in the gene sets they examined are not normally distributed. When the population from which we are sampling does not have a normal distribution, the normal approximation method will generally have less power than the permutation method to detect real relationships. The non-normality also suggests that a non-parametric test, such as the Wilcoxon rank sum test, is likely preferable to the SNR or t-statistics which yield parametric tests in the standard GSEA. The fact that the PAGE method was able to detect genes sets not detected by standard GSEA, and that the p-values for gene sets detected by PAGE were smaller than the corresponding GSEA p-values, is not necessarily evidence that the PAGE method is superior; predicting more pathways with p-values less than p = 0.05 does not mean that the predictions are correct, and smaller p-values do not necessarily imply more accurate p-values. The Central Limit Theorem indicates that, as the number of genes in the gene set increases, the normal approximation becomes asymptotically more accurate, but it doesn't tell us how quickly we approach the normal approximation. Based on previous statistics studies, a sample size of 30 genes should have good convergence to the normal distribution, while a sample size of 10 genes may deviate greatly from the normal approximation, in which case the p-values are not necessarily accurate, and a t-test may better capture the variance in the distribution. Many known pathways have fewer than 10 genes, and a large proportion have fewer than the 30 genes that should give good convergence to the normal approximation. Because the standard GSEA does not take excessive time to run on current computers, and because the permutation test is generally more powerful than the normal approximation for non-normally distributed populations, more evidence is required to show that PAGE is preferable to standard GSEA.
Further extensions to gene set enrichment. Jiang and Gentleman [16] offer several extensions to standard GSEA, including the ability to control for additional factors (covariates) that affect gene expression, alternative measures of association, and the ability to analyze genes with correlated expression in the context of GSEA. We begin with the ability to control for additional factors. When we analyze gene expression data, we commonly compare two phenotypes (such as healthy versus disease), but we know that other factors (such as age, gender, previous medical history, and so on) may also cause changes in gene expression. These additional factors usually increase the variability in gene expression within each phenotype; if we do not control or adjust for these other factors, we may not be able to detect a significant effect due to the factor of interest (healthy versus disease), or, in pathologic cases, we may attribute an effect to one factor that is genuinely the caused by another factor. Standard GSEA cannot readily adjust for covariates. In conventional statistics, the t-test is the analogue of the method used in standard GSEA, and the t-test does not provide a method to adjust for covariates. However, the t-test can be readily generalized to a linear regression model, which can adjust for covariates. Jiang and Gentleman present a formulation of a GSEA-like algorithm that uses linear regression, and thus allows for adjustment for age, gender, or any other variable that we can measure and believe may be affecting gene expression. We will not go into details of the algorithm, but instead refer readers to the paper.
Our aim in this paper is to provide a tutorial overview, rather than a comprehensive survey, so this list of GSEA extensions and alternatives is not exhaustive. Further variants and enhancements appear steadily, such as pathway analysis using random forests from Pang, Lin, and colleagues [17] so the reader is encouraged to search the literature databases for the most current publications.
LIMITATIONS TO GSEA AND CAVEATS FOR US-ERS
Several authors have noted limitations to the GSEA algorithm and offer caveats and guidance for users.
Jiang and Gentleman [16] has noted that, for many of the GSEA-related methods, there is an implicit assumption that the effects for all genes are on essentially the same scale. For this and other reasons, it is advisable to standardize the expression values for each gene before performing any GSEA analysis. Standardization may be done as a z-score (original value minus the mean, divided by the standard deviation) or the median score (original value minus the median, divided by the median absolute deviation).
The authors of the existing implementations of GSEA and related algorithms indicate that the pre-defined gene sets work poorly if the number of genes in the set is too small; they suggest that a gene set should contain a minimum of 8 or 10 genes. Many known pathways have fewer than 8 or 10 genes, which limits the present utility of GSEA.
If the microarray experiment includes a small number of samples from each phenotype, then the permutation test for statistical significance will tend to give less accurate estimates of the p-values. Saxena and colleagues suggest at least eight samples in each phenotype [13] . Bild and Febbo [3] , among others, note that the quality of the GSEA results depends directly on the quality of the pre-defined gene sets.
The GSEA implementation from Subramanian and colleagues is freely available, but does not include many of the subsequently published enhancements. Many of the later enhancements are not available in public, readily accessible software.
POSSIBLE FUTURE RESEARCH DIRECTIONS
We can identify several potential directions for future research on GSEA and related methods.
Additional gene sets will be defined, and existing gene sets will be refined, which will increase the capability of GSEA. In turn, GSEA is now being used in efforts to validate and refine putative pathways, in what will hopefully prove to be a positive feedback loop.
GSEA appears to have greater power than single gene analysis to detect small but biologically important changes in a set of genes. While statistical procedures are available to estimate power and sample size for single gene analysis, we are not aware of any published methods for estimating power and sample size for GSEA. It would be useful, particularly when designing clinical studies to identify disease-related genes, to be able to estimate the sample size required to detect an effect using GSEA, and to estimate the power for a given available sample size.
GSEA may be applied to genotype data, as well as gene expression data. It will be useful to examine issues that arise in applying GSEA to find genotypes related to disease. The algorithm will likely need some modification to deal with categorical data (different alleles), dominant/recessive effects, linkage disequilibrium, and related genetic issues.
Ideally, GSEA analyses will contribute to the development of molecular tests for diagnosis or to predict or monitor response to therapy. Further research is needed to determine how GSEA results (derived from a population of samples) may best be used to develop diagnostic, prognostic, and predictive algorithms that apply to individual patients. We expect to see more alternatives to the permutation test for statistical significance, and exact methods developed for experiments that have small numbers of samples per phenotype or small numbers of genes in a gene set. The gene expression values for genes in a gene set commonly do not follow the normal distribution (as noted by Kim and Volsky [15] ), which suggests that a non-parametric test, such as the Wilcoxon, may be more robust than the SNR or t-statistic used in the standard GSEA. Correlation statistics are also generally not normally distributed, suggesting the use of nonparametric methods. Further studies of alternative measures of association (such as Spearman rank correlation, robust regression, paired t-test, Wilcoxon signed rank test) can help guide selection of the best association measures.
CONCLUSIONS
We have described the original GSEA algorithm, several extensions and alternatives, results of some of the applications, some limitations of the methods, and possible future research directions. GSEA and related methods are complementary to conventional single-gene methods. Single gene methods work best when individual genes have large effects and there is small variance within the phenotype. GSEA is likely to be more powerful than conventional single-gene methods for studying the large number of common diseases in which many genes each make subtle contributions. It is a tool that deserves to be in the toolbox of bioinformatics practitioners.
